335 related articles for article (PubMed ID: 31876275)
1. [The Role of Mutant RNA in the Pathogenesis of Huntington's Disease and Other Polyglutamine Diseases].
Bogomazova AN; Eremeev AV; Pozmogova GE; Lagarkova MA
Mol Biol (Mosk); 2019; 53(6):954-967. PubMed ID: 31876275
[TBL] [Abstract][Full Text] [Related]
2. [The advances in research on phosphorylation of polyglutamine disease].
Zhou YF; Jiang H; Tang JG; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
[TBL] [Abstract][Full Text] [Related]
3. Polyglutamine (PolyQ) diseases: genetics to treatments.
Fan HC; Ho LI; Chi CS; Chen SJ; Peng GS; Chan TM; Lin SZ; Harn HJ
Cell Transplant; 2014; 23(4-5):441-58. PubMed ID: 24816443
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biology of polyglutamine diseases].
Owecki M; Kozubski W
Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics and biomarkers of polyglutamine diseases.
Katsuno M; Banno H; Suzuki K; Takeuchi Y; Kawashima M; Tanaka F; Adachi H; Sobue G
Curr Mol Med; 2008 May; 8(3):221-34. PubMed ID: 18473821
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects.
Bonsor M; Ammar O; Schnoegl S; Wanker EE; Silva Ramos E
Proteomics; 2024 Jun; 24(12-13):e2300114. PubMed ID: 38615323
[TBL] [Abstract][Full Text] [Related]
7. Autophagy and Polyglutamine Disease.
Ren H; Hao Z; Wang G
Adv Exp Med Biol; 2020; 1207():149-161. PubMed ID: 32671744
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of SCA3 and implications for other polyglutamine diseases.
McLoughlin HS; Moore LR; Paulson HL
Neurobiol Dis; 2020 Feb; 134():104635. PubMed ID: 31669734
[TBL] [Abstract][Full Text] [Related]
9. The Expanding Clinical Universe of Polyglutamine Disease.
Huang S; Zhu S; Li XJ; Li S
Neuroscientist; 2019 Oct; 25(5):512-520. PubMed ID: 30614396
[TBL] [Abstract][Full Text] [Related]
10. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
Suzuki Y; Jin C; Yazawa I
Neurosci Lett; 2013 Sep; 552():156-61. PubMed ID: 23933208
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.
Xiang C; Zhang S; Dong X; Ma S; Cong S
Front Mol Neurosci; 2018; 11():153. PubMed ID: 29867345
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.
Ross CA
Neuron; 2002 Aug; 35(5):819-22. PubMed ID: 12372277
[TBL] [Abstract][Full Text] [Related]
13. The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology.
Stoyas CA; La Spada AR
Handb Clin Neurol; 2018; 147():143-170. PubMed ID: 29325609
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Silva AC; Lobo DD; Martins IM; Lopes SM; Henriques C; Duarte SP; Dodart JC; Nobre RJ; Pereira de Almeida L
Brain; 2020 Feb; 143(2):407-429. PubMed ID: 31738395
[TBL] [Abstract][Full Text] [Related]
15. Huntingtin aggregation and toxicity in Huntington's disease.
Bates G
Lancet; 2003 May; 361(9369):1642-4. PubMed ID: 12747895
[TBL] [Abstract][Full Text] [Related]
16. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.
Wyttenbach A
J Mol Neurosci; 2004; 23(1-2):69-96. PubMed ID: 15126694
[TBL] [Abstract][Full Text] [Related]
17. Trinucleotide repeat expansion in neurological disease.
La Spada AR; Paulson HL; Fischbeck KH
Ann Neurol; 1994 Dec; 36(6):814-22. PubMed ID: 7998766
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
Preisinger E; Jordan BM; Kazantsev A; Housman D
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
[TBL] [Abstract][Full Text] [Related]
19. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations.
Wanker EE
Biol Chem; 2000; 381(9-10):937-42. PubMed ID: 11076024
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
